Experiments for taxon Ganoderma lucidum (GANODERMATACEAE)

Experiments (1103 results)

Filters
Worktypes (50)
229
206
204
199
183
172
165
158
144
137
136
80
78
47
25
21
18
15
15
12
9
5
5
5
5
5
4
4
4
4
4
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Pharmacology (187)
68
63
44
40
23
22
18
15
15
14
13
13
13
11
11
11
9
9
8
8
8
8
7
6
6
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
371
No match
Compounds (283)
26
26
17
16
15
13
13
13
12
12
12
12
12
11
10
10
10
9
9
8
8
7
7
7
7
7
7
7
7
7
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
450
No match
Organisms (257)
54
35
25
24
23
21
21
20
19
19
16
14
14
14
14
14
13
13
13
12
11
10
10
10
10
10
9
9
9
9
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
1103 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
829812
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID B
1201297
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
STEARIC ACID
242524
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
CEREVISTEROL
476940
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTICOMPLEMENT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
79036
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID G
1304177
MEDICINAL FOLKLORE REPORTED FOR
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228091
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
CEREVISTEROL
694514
PHARMACOLOGY OF EXTRACT - IN VIVO
NATURAL KILLER CELL ENHANCEMENT
Ganoderma lucidum (GANODERMATACEAE)
1296568
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL MIGRATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
727434
IDENTIFICATION IN BY TLC
Ganoderma lucidum (GANODERMATACEAE)
URACILADENINEURIDINEADENOSINE
72701
PHARMACOLOGY OF COMPOUND - IN HUMANS
BITTER TASTING EFFECT
Ganoderma lucidum (GANODERMATACEAE)
LUCIDONE A
1296460
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1117107
MEDICINAL FOLKLORE REPORTED FOR
DIURETIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1028138
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
1149851
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIRADIATION EFFECT
Ganoderma lucidum (GANODERMATACEAE)
301331
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROLERGOSTA-7-22-DIEN-3-BETA-OL
824362
PHARMACOLOGY OF EXTRACT - IN VIVO
DNA SYNTHESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
72279
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID D
74485
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID D
838319
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN A
655660
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
955495
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERAL A
84809
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMATRIOL
246147
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-4-6-8(14)-22-TETRAEN-3-ONE
657115
PHARMACOLOGY OF EXTRACT - IN VITRO
CARCINOGENESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
397632
PHARMACOLOGY OF EXTRACT - IN VITRO
DNA POLYMERASE BETA INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
STEARIC ACID
228085
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
848520
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
86157
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM TRITERPENE 17-A
597268
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE GLB
86156
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM TRITERPENE 18-A
808259
REVIEW OF
Ganoderma lucidum (GANODERMATACEAE)
242513
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
965968
IDENTIFICATION IN BY HPLC
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID HGANODERIC ACID AGANODERIC ACID SGANODERIC ACID BGANODERIC ACID R
270118
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID N
953404
PHARMACOLOGY OF EXTRACT - IN VITRO
BENZODIAZEPINE BINDING INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
941850
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID T
399112
PHARMACOLOGY OF COMPOUND - IN VITRO
REVERSE TRANSCRIPTASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-STEAROYL-1-O-BETA-D-GLUCOPYRANOSYL-9-METHYL:
860891
PHARMACOLOGY OF COMPOUND - IN VIVO
CYTOCHROME P450 INDUCTION
Ganoderma lucidum (GANODERMATACEAE)
LINGZHI POLYSACCHARIDE D-6
1020795
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC GL-2
860888
PHARMACOLOGY OF COMPOUND - IN VIVO
PROTEIN SYNTHESIS STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
LINGZHI POLYSACCHARIDE D-6
426141
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ganoderma lucidum (GANODERMATACEAE)
1302524
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
441747
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
642228
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
HORMONAL EFFECTS(UNSPECIFIED)
Ganoderma lucidum (GANODERMATACEAE)
1149847
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1208957
PHARMACOLOGY OF EXTRACT - IN VIVO
ALKALINE PHOSPHATASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1185161
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
286451
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOMODULATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID J,8-BETA-9-ALPHA-DIHYDRO:
769989
VOUCHER SPECIMEN REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
286463
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID DM
1156033
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION H
228049
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
549421
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOMODULATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
869820
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANOLUCIDIC ACID EGANODERIOL EGANODERIOL IGANODERIOL FGANODERIOL DGANODERIOL CGANODERIOL HGANODERIOL G
953410
PHARMACOLOGY OF EXTRACT - IN VITRO
COMPLEMENT(GENERAL) ENZYME INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
923601
PHARMACOLOGY OF EXTRACT - IN VIVO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
859466
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANONDIOL
671625
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
74482
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID I
566467
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
79039
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
652263
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1212595
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTICONVULSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
856822
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN C
1174679
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIALLERGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
650012
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
566453
PHARMACOLOGY OF EXTRACT - IN VITRO
SPASMOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
955489
PHARMACOLOGY OF EXTRACT - IN VITRO
INOTROPIC EFFECT POSITIVE
Ganoderma lucidum (GANODERMATACEAE)
642227
PHARMACOLOGY OF EXTRACT - IN VITROEFFECTS DUE TO A COMBINATION OF DRUGS
PSA(PROSTATE-SPECIFIC ANTIGEN) PRODUCTION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
86149
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
649845
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
688433
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
425644
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
838321
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN B
610805
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
207305
PHARMACOLOGY OF COMPOUND - IN VITRO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
74463
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
657110
PHARMACOLOGY OF EXTRACT - IN VITRO
CARCINOGENESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
242517
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
258715
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID EPSILON
391364
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1208954
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
694517
PHARMACOLOGY OF EXTRACT - IN VIVO
CELL DIFFERENTIATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1176017
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERTENSIVE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
286459
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-6-22-DIEN-3-BETA-OL,5-ALPHA-8-ALPHA-EPIDIOXY:
609614
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE PRODUCTION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1201291
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LINOLEIC ACID
86138
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID A
201948
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOMODULATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
687489
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
895323
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
629175
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERENIC ACID A
399106
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE ALPHA INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-PALMITOYL-1-O-BETA-ED-GLUCOPYRANOSYL-9-METHYL:
666064
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
941846
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODOSTERONE
387204
UV SPECTRUM GIVEN FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
445773
PHARMACOLOGY OF EXTRACT - IN VIVO
LYMPHOCYTE BLASTOGENESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
138792
PHARMACOLOGY OF COMPOUND - IN VIVO
PLAQUE FORMING CELL STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-C
859590
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMATRIOL
138785
PHARMACOLOGY OF COMPOUND - IN VITRO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-A
733785
VOUCHER SPECIMEN REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
72282
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
1302528
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANONTRIOL
1198628
MEDICINAL FOLKLORE REPORTED FOR
LIVER EFFECTS(UNSPECIFIED)
Ganoderma lucidum (GANODERMATACEAE)
74460
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID A
1156013
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION B
209533
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID DM
288551
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
HETEROGLYCAN PL-4GLUCAN PL-3HETEROGLYCAN PL-1
401068
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1303005
PHARMACOLOGY OF EXTRACT - IN VITRO
LYMPHOCYTE PROLIFERATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
99223
PHARMACOLOGY OF COMPOUND - IN VITRO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
1212594
PHARMACOLOGY OF EXTRACT - IN VIVO
SKELETAL MUSCLE RELAXANT EFFECT(CENTRAL)
Ganoderma lucidum (GANODERMATACEAE)
116056
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA PROTEIN LING-ZHI 8
138788
PHARMACOLOGY OF COMPOUND - IN VIVO
PLAQUE FORMING CELL STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-B
655655
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
258723
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-2
782232
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
85547
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID D
923605
PHARMACOLOGY OF EXTRACT - IN VIVO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
457983
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
929581
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1296588
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
371000
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
258720
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID THETA
86153
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANOLUCIDENIC ACID B
274722
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE GLB-3POLYSACCHARIDE GLB-7POLYSACCHARIDE GLB-2POLYSACCHARIDE GLC-1POLYSACCHARIDE GLB-6POLYSACCHARIDE GLB 9POLYSACCHARIDE GLC-2POLYSACCHARIDE GLB-1POLYSACCHARIDE GLB-4
842133
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1034509
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIHYPERTENSIVE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC
655658
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
286462
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H,12-DEACETYL:
745366
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
242504
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
566463
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
457984
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
566457
PHARMACOLOGY OF EXTRACT - IN VIVO
GASTRIC SECRETORY STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
86142
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
1212599
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTICONVULSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
234586
PHARMACOLOGY OF COMPOUND - IN VITRO
MEMBRANE POTENTIAL SHIFT
Ganoderma lucidum (GANODERMATACEAE)
LUCIDUMOL A
953405
PHARMACOLOGY OF EXTRACT - IN VITRO
DOPAMINE RECEPTOR BLOCKING EFFECT
Ganoderma lucidum (GANODERMATACEAE)
902506
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
525547
PHARMACOLOGY OF EXTRACT - IN HUMANS
ALLERGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
783214
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID F
258712
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ZETAGANODERIC ACID EPSILONGANOLUCIDIC ACID DGANODERIC ACID DELTAGANODERIC ACID C-2GANODERIC ACID GAMMAGANODERIC ACID ETA
637258
MEDICINAL FOLKLORE REPORTED FOR
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
566458
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1156024
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION E
1156030
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION G
1201285
PHARMACOLOGY OF EXTRACT - IN VITRO
HISTAMINE RELEASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
671626
PHARMACOLOGY OF EXTRACT - IN VITRO
HYDROGEN PEROXIDE SECRETION STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
1282829
CLINICAL STUDIES
TOXIC EFFECT(GENERAL)
Ganoderma lucidum (GANODERMATACEAE)
1297351
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERLIPEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
760437
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1156018
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION C
1290857
PHARMACOLOGY OF COMPOUND - IN VITRO
REDUCTASE,5-ALPHA: INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID DM
270129
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID E
290654
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICOMPLEMENT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-6LUCIDENIC ACID SP-1GANODERIC ACID AGANODERIC ACID GGANODERIC ACID B
955505
PHARMACOLOGY OF COMPOUND - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
CHRYSOPHANIC ACID GLUCOSIDE
286466
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID G
713587
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1174606
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
79040
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
182318
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
72289
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
MANNITOL
1156029
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION G
167346
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE,5'-DEOXY-5'-METHYL-SULFINYL: 1-EPI:
209534
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LANOST-8-EN-26-OIC ACID,5-ALPHA: 7-BETA-15-ALPHA-DIHYDROXY-3-11-23-TRIOXO:
679805
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
286455
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOMODULATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID J,8-BETA-9-ALPHA-DIHYDRO:
1283708
PHARMACOLOGY OF COMPOUND - IN VITRO
APOPTOSIS INDUCTION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID T
1284868
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
PALMITIC ACID
167342
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE,5'-DEOXY-5'-METHYL-SULFINYL:
74464
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
794323
VOUCHER SPECIMEN REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
783209
VOUCHER SPECIMEN REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
610803
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
991050
PHARMACOLOGY OF COMPOUND - IN VIVOAMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE(GANODERMA LUCIDUM)
228052
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
263293
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIENE-3-22-DIONE,5-ALPHA: 26-27-DIHYDROXY:
949200
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
421714
PHARMACOLOGY OF EXTRACT - IN VITRO
PHAGOCYTOSIS RATE INCREASED
Ganoderma lucidum (GANODERMATACEAE)
873847
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE
838563
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
89429
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID K
629171
PHARMACOLOGY OF EXTRACT - IN VIVO
ASPARTATE AMINOTRANSFERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1201292
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LINOLEIC ACID
650006
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1212588
MEDICINAL FOLKLORE REPORTED FOR
BRONCHODILATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
694516
PHARMACOLOGY OF EXTRACT - IN VIVO
INTERFERON INDUCTION STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
228063
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
277142
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE GLB
417530
EFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Ganoderma lucidum (GANODERMATACEAE)
89430
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
686398
PHARMACOLOGY OF EXTRACT - IN VITRO
UREASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
234602
PHARMACOLOGY OF COMPOUND - IN VITRO
MEMBRANE POTENTIAL SHIFT
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-1
270132
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID E
263298
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIENE-3-22-DIONE,5-ALPHA: 26-HYDROXY:
72696
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID D
566450
PHARMACOLOGY OF EXTRACT - IN VIVO
BILE SECRETION INCREASE
Ganoderma lucidum (GANODERMATACEAE)
694510
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
234590
PHARMACOLOGY OF COMPOUND - IN VITRO
MEMBRANE POTENTIAL SHIFT
Ganoderma lucidum (GANODERMATACEAE)
LUCIDUMOL B
666067
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIMALARIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
122929
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-6-9(11)-22-TRIEN-3-BETA-OL,5-ALPHA-8-ALPHA-EPI-DIOXY:
953409
PHARMACOLOGY OF EXTRACT - IN VITRO
HMG-CO-A REDUCTASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
873850
PHARMACOLOGY OF COMPOUND - IN VIVO
PROTECTIVE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE
873180
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1302525
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
STELLASTEROL
561362
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
258718
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ETA
568687
PHARMACOLOGY OF EXTRACT - IN VIVO
RADIOPROTECTIVE EFFECT
Ganoderma lucidum (GANODERMATACEAE)
242501
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
270122
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENOLACTONE
584219
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
79031
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERENIC ACID B
748876
PHARMACOLOGY OF EXTRACT - IN VIVO
LIVER EFFECTS(UNSPECIFIED)
Ganoderma lucidum (GANODERMATACEAE)
1201289
PHARMACOLOGY OF COMPOUND - IN VITRO
CALCIUM ION UPTAKE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
OLEIC ACID
234597
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
697751
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLIC AMP STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
74489
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID D
447605
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
PROTEOGLYCAN-G009
1212591
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
72275
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1156022
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION E
242520
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
955492
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID S-1
561361
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
510745
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
246143
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL,22-23-DIHYDRO:
234362
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BGANODERMA POLYSACCHARIDE A
902501
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
85551
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID E-2
270121
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID N
723126
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC POLYSACCHARIDEGANODERIC ACID
655665
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
955508
PHARMACOLOGY OF COMPOUND - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
PORTENSTEROL
242507
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
787816
PHARMACOLOGY OF EXTRACT - IN VITRO
GLUTATHIONE PEROXIDASE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
789786
CRUDE DRUG DESCRIPTIONMICROSCOPY OFREVIEW OF
Ganoderma lucidum (GANODERMATACEAE)
955484
MEDICINAL FOLKLORE REPORTED FOR
CNS DEPRESSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1284871
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
MYRISTIC ACID
228089
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
CEREVISTEROL
1174684
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIALLERGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
89426
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID J
860883
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LINGZHI POLYSACCHARIDE D-6
794328
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
99224
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOMODULATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
228075
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL F
86319
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID R
863729
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID MK
387201
UV SPECTRUM GIVEN FORCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
1156011
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION A
1024544
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID VGANODERIC ACID XGANODERIC ACID TGANODERIC ACID WGANODERIC ACID YGANODERIC ACID Z
943263
PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
75388
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
711654
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
782237
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
399110
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE II INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-STEAROYL-1-O-BETA-D-GLUCOPYRANOSYL-9-METHYL:
182317
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
1297244
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
856819
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN B
441743
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
885025
IDENTIFICATION IN BY HPLC
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIEN-15-ALPHA-22-BETA-DIACETOXY-3-BETA-HYDROXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-15-ALPHA-ACETOXY-3-ALPHA-HYDROXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-3-ALPHA-22-BETA-DIACETOXY-15-ALPHA-HYDROXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-3-ALPHA-ACETOXY-15-ALPHA-HYDROXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-3-BETA-15-ALPHA-22-BETA-TRIACETOXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-3-BETA-15-ALPHA-DIACETOXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-15-ALPHA-ACETOXY-3-BETA-HYDROXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-3-BETA-15-ALPHA-DIHYDROXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-3-ALPHA-ACETOXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-3-ALPHA-15-ALPHA-22-BETA-TRIACETOXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-3-ALPHA-15-ALPHA-DIHYDROXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-3-BETA-ACETOXY-15-ALPHA-HYDROXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-3-ALPHA-15-ALPHA-DIACETOXY-26-OIC ACIDLANOSTA-7-9(11)-24-TRIEN-3-ALPHA-HYDROXY-26-OIC ACID
399111
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE GAMMA INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-STEAROYL-1-O-BETA-D-GLUCOPYRANOSYL-9-METHYL:
829811
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID A
713374
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INDUCTION
Ganoderma lucidum (GANODERMATACEAE)
425647
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
856821
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN B
782238
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
1208962
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERTRIGLYCERIDEMIA EFFECT
Ganoderma lucidum (GANODERMATACEAE)
657109
PHARMACOLOGY OF EXTRACT - IN VITRO
CARCINOGENESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
650011
PHARMACOLOGY OF EXTRACT - IN VIVO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
840028
IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GUANOSINE-5'-MONOPHOSPHATEXANTHOSINE-5'-MONOPHOSPHATE
955496
PHARMACOLOGY OF COMPOUND - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
GANODERAL A
89431
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID N
72273
MEDICINAL FOLKLORE REPORTED FOR
CNS DEPRESSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
279003
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
510746
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
566461
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
81546
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDHPLC DATA REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
902500
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
649848
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
629174
PHARMACOLOGY OF EXTRACT - IN VIVO
ALANINE AMINOTRANSFERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1296567
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL MIGRATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
207306
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
270126
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID A
782239
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H,DEACETYL:
964022
MEDICINAL FOLKLORE REPORTED FOR
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
895321
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
441749
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
278997
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE NPBP
773240
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE GLB-7
1324238
TRADITIONAL MEDICINEEFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
234594
PHARMACOLOGY OF COMPOUND - IN VITRO
MEMBRANE POTENTIAL SHIFT
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL F
666063
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1176014
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIALLERGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1297246
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
286458
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIEN-3-BETA-OL
229159
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-TRANS-22-DIEN-3-ONE
896726
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
955488
PHARMACOLOGY OF EXTRACT - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
941847
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODOSTERONE
629176
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERENIC ACID A
1185217
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1157288
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTIHYPERTENSIVE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1149850
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPOXIC EFFECT
Ganoderma lucidum (GANODERMATACEAE)
1198629
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR
GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
72278
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
74488
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
228079
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
1207230
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
CYCLOOCTASULFUR
258721
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID THETA
629179
PHARMACOLOGY OF COMPOUND - IN VIVO
LACTATE DEHYDROGENASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERENIC ACID A
201950
PHARMACOLOGY OF COMPOUND - IN VITRO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
85885
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANOLUCIDIC ACID B
246148
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANODIOL
657114
PHARMACOLOGY OF EXTRACT - IN VITRO
CARCINOGENESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
79033
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERENIC ACID D
1149848
PHARMACOLOGY OF EXTRACT - IN VIVO
PHAGOCYTOSIS CAPACITY INCREASED
Ganoderma lucidum (GANODERMATACEAE)
1208958
PHARMACOLOGY OF EXTRACT - IN VIVO
LACTATE DEHYDROGENASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
655656
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
955513
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-2
829815
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
286470
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
74461
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID B
955507
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
PORTENSTEROL
943257
PHARMACOLOGY OF EXTRACT - IN VITRO
PEPSIN INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1290861
PHARMACOLOGY OF COMPOUND - IN VITRO
REDUCTASE,5-ALPHA: INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDUMOL BGANODERIC ACID AGANODERMANOTRIOLGANODERENIC ACID AGANODERMADIOLGANODERIC ACID DGANODERIOL A
450816
PHARMACOLOGY OF EXTRACT - IN VIVO
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
72286
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
1290859
PHARMACOLOGY OF COMPOUND - IN VITRO
REDUCTASE,5-ALPHA: INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIEN-3-ONE,15-ALPHA-26-DIHYDROXY:
290657
UV SPECTRUM GIVEN FORQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-6
1156032
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION H
727433
IDENTIFICATION IN BY TLC
Ganoderma lucidum (GANODERMATACEAE)
URACILADENINEURIDINEADENOSINE
74483
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANOLUCIDIC ACID A
270119
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID N
679806
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
652262
VOUCHER SPECIMEN REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
209497
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-DIENE-3-BETA-24-25-26-TETROL,5-ALPHA:
902504
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1208959
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERBILIRUBINEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
566452
PHARMACOLOGY OF EXTRACT - IN VITRO
SPASMOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
655663
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
782234
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
138793
PHARMACOLOGY OF COMPOUND - IN VIVO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-C
629168
PHARMACOLOGY OF EXTRACT - IN VITRO
BETA-GLUCURONIDASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
89420
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID M
84807
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERMENONOL
549420
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOMODULATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
955502
PHARMACOLOGY OF COMPOUND - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
CHRYSOPHANIC ACID
1000691
CRUDE DRUG DESCRIPTION
Ganoderma lucidum (GANODERMATACEAE)
277143
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE GLB
650007
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
72281
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID D
782228
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
99222
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIANAPHYLACTIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
116055
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL GROWTH ENHANCEMENT EFFECT
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA PROTEIN LING-ZHI 8
286452
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOMODULATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID J,8-BETA-9-ALPHA-DIHYDRO:
1156019
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION D
228046
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ALPHA
657111
PHARMACOLOGY OF EXTRACT - IN VITRO
CARCINOGENESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
391365
PHARMACOLOGY OF EXTRACT - IN VIVO
RETICULOENDOTHELIAL SYSTEM ACTIVATION
Ganoderma lucidum (GANODERMATACEAE)
923602
PHARMACOLOGY OF EXTRACT - IN VIVO
RESPIRATORY STIMULANT EFFECT
Ganoderma lucidum (GANODERMATACEAE)
754928
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
167349
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE,5'-DEOXY-5'-METHYL-SULFINYL: 1-EPI:
201947
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
74490
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID E
863726
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID MG
242500
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
1284865
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIANDROGENIC EFFECT
Ganoderma lucidum (GANODERMATACEAE)
748879
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDE FORMATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
366640
PHARMACOLOGY OF EXTRACT - IN VIVO
ASPARTATE TRANSAMINASE LEVEL DECREASE
Ganoderma lucidum (GANODERMATACEAE)
1185635
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDX-RAY DIFFRACTION STUDY OFQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID T
649852
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
895322
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
399107
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE BETA INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-PALMITOYL-1-O-BETA-ED-GLUCOPYRANOSYL-9-METHYL:
426144
PHARMACOLOGY OF EXTRACT - IN VIVO
CORONARY RESISTANCE DECREASED
Ganoderma lucidum (GANODERMATACEAE)
595975
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
301329
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
CHOLESTA-11-15-DIOXO-8-EN-24-OIC ACID,5-ALPHA: 3-BETA-OXO-FORMYL-7-BETA-12-BETA-DIHYDROXY-4-4-14-ALPHA-TRIMETHYL: TRANS:
441744
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
902499
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228090
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
CEREVISTEROL
655652
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
138782
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-A
425645
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
457982
MEDICINAL FOLKLORE REPORTED FOR
APHRODISIAC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
787817
PHARMACOLOGY OF EXTRACT - IN VITRO
CATALASE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
922606
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
85884
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANOLUCIDIC ACID A
286469
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-2
242516
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
1201296
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
STEARIC ACID
1181169
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID M-BGANODERIC ACID M-FGANODERIC ACID M-AGANODERIC ACID M-EGANODERIC ACID M-DGANODERIC ACID M-C
783212
PHARMACOLOGY OF EXTRACT - IN VITRO
DNA SYNTHESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
277146
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE GLE
889458
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERTENSIVE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1304305
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1020796
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC GL-3
873181
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
72702
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID D
745367
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
167343
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE,5'-DEOXY-5'-METHYL-SULFINYL:
86137
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID F
652266
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1185639
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID P
417202
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED
SKIN DEPIGMENTATION EFFECT
Ganoderma lucidum (GANODERMATACEAE)
566456
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
711657
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE SCAVENGING ACTIVITY INCREASE
Ganoderma lucidum (GANODERMATACEAE)
86154
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM TRITERPENE 5-A
783213
PHARMACOLOGY OF EXTRACT - IN VITRO
ANGIOGENESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
258711
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID GAMMA
228062
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
228045
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ALPHA
860885
PHARMACOLOGY OF COMPOUND - IN VIVO
RNA SYNTHESIS STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
LINGZHI POLYSACCHARIDE D-6
873846
PHARMACOLOGY OF COMPOUND - IN VIVO
SPONTANEOUS ACTIVITY REDUCTION
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE
754925
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
1020789
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC GL-1
1302529
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDESTELLASTEROLERGOSTEROLERGOSTEROL PEROXIDE,9(11)-DEHYDRO:
782230
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
266182
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIBODY ACTIVITY ENHANCEMENT
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE SP
838322
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN B
1208961
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERLIPEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
597271
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE GLC
242510
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
713375
PHARMACOLOGY OF EXTRACT - IN VIVO
PROTEIN EXPRESSION STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
1284872
IDENTIFICATION IN BY HPLC
Ganoderma lucidum (GANODERMATACEAE)
GANODEROL BGANODERMANOTRIOLGANODERIC ACID GGANODERIC ACID C-2
955485
ANTICANCER AND/OR CYTOTOXICITY MARKER CODEMEDICINAL FOLKLORE REPORTED FOR
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
258714
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ZETAGANOLUCIDIC ACID DGANODERIC ACID DELTAGANODERIC ACID C-2GANODERIC ACID ETA
1185218
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTICOAGULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
955503
PHARMACOLOGY OF COMPOUND - IN VITRO
INOTROPIC EFFECT POSITIVE
Ganoderma lucidum (GANODERMATACEAE)
CHRYSOPHANIC ACID
270125
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID A
1275003
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODINEPYRRYL-ALDEHYDE,N-(2'-METHYL-PENTYL)-5-HYDROXY-METHYL:GANOINE
636102
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
754924
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
167345
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE,5'-DEOXY-5'-METHYL-SULFINYL:
1296168
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
655657
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
848519
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228051
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
1283852
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228093
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:
943262
PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1212596
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOTHERMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1212601
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
445772
PHARMACOLOGY OF EXTRACT - IN VIVO
PHAGOCYTOSIS STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
953406
PHARMACOLOGY OF EXTRACT - IN VITRO
ENDORPHIN BINDING INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
893152
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
NONADECANOIC ACIDCHOLINETETRACOSANE,N:HENTRIACONTANE,N:STEARIC ACIDBETAINEPALMITIC ACIDLIGNOCERIC ACIDBEHENIC ACIDERGOSTEROLSITOSTEROL,BETA:ERGOSTA-7-22-DIEN-3-BETA-OL
441740
ANTICANCER AND/OR CYTOTOXICITY MARKER CODEMEDICINAL FOLKLORE REPORTED FOR
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
741520
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
525548
PHARMACOLOGY OF EXTRACT - IN HUMANS
ALLERGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
138786
PHARMACOLOGY OF COMPOUND - IN VITRO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-A
228082
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
566459
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIYEAST ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
278994
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE NPBP
838564
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
72271
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
72703
PHARMACOLOGY OF COMPOUND - IN HUMANS
BITTER TASTING EFFECT
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID D
242503
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
1155664
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Ganoderma lucidum (GANODERMATACEAE)
1290862
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDUMOL BGANODERIC ACID AGANODERMANOTRIOLGANODERENIC ACID AGANODERMADIOLGANODERIC ACID DGANODERIOL A
258722
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANOLUCIDIC ACID D
1290858
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID DM
781819
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
348788
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GERMANIUM
286465
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID I METHYL ESTER
873851
PHARMACOLOGY OF COMPOUND - IN VIVO
SKELETAL MUSCLE RELAXANT EFFECT(CENTRAL)
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE
447604
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTILEPROTIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
PROTEOGLYCAN-G009
192959
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LECTIN GLL-M
86318
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID S
1034508
UV SPECTRUM GIVEN FORISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC
122925
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-6-22-DIEN-3-BETA-OL,5-ALPHA-8-ALPHA-EPI-DIOXY: LINOLEATE
79041
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID D
713588
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
566464
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
629170
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
301330
X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-11-15-23-TRIOXO-8-EN-26-OIC ACID,5-ALPHA: 3-BETA-OXO-FORMYL-7-BETA-12-DIHYDROXY: TRANS:
1174682
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIALLERGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1117108
MEDICINAL FOLKLORE REPORTED FOR
LAXATIVE EFFECT
Ganoderma lucidum (GANODERMATACEAE)
266179
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE SP
722856
IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
URIDINEADENOSINE
89428
UV SPECTRUM GIVEN FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID H
610800
PHARMACOLOGY OF EXTRACT - IN VITRO
TUMOR NECROSING FACTOR RELEASE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
1156021
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION D
740969
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1181170
CMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID TGANODERIC ACID WGANODERIC ACID R
421715
PHARMACOLOGY OF EXTRACT - IN VITRO
TUMOR NECROSING FACTOR INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
860889
PHARMACOLOGY OF COMPOUND - IN VIVO
DNA STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
LINGZHI POLYSACCHARIDE D-6
86148
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID G
733786
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
387203
PHARMACOLOGY OF COMPOUND - IN VITRO
GERANYLGERANYL-PROTEIN TRANSFERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
935437
PHARMACOLOGY OF EXTRACT - IN VIVO
RADIOPROTECTIVE EFFECT
Ganoderma lucidum (GANODERMATACEAE)
1201286
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
OLEIC ACID
397635
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE BETA INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
234591
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANODIOL
1201293
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
LINOLEIC ACID
286454
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOMODULATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID J,8-BETA-9-ALPHA-DIHYDRO:
85546
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID G
86320
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID R
242508
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
955481
MEDICINAL FOLKLORE REPORTED FOR
BRONCHODILATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
533246
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
650008
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
874741
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
270131
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID E
242521
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
655664
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
694511
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
514361
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
86150
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID I
228086
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
842132
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1212592
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
182319
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID D
955499
PHARMACOLOGY OF COMPOUND - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
CHOLESTA-6-22-DIEN-3-BETA-OL,5-ALPHA-8-ALPHA-EPI-DIOXY-24-EPSILON-METHYL:
739601
REVIEW OF
Ganoderma lucidum (GANODERMATACEAE)
739043
PHARMACOLOGY OF EXTRACT - IN VITRO
PROTEIN KINASE A ACTIVATION
Ganoderma lucidum (GANODERMATACEAE)
421717
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-1 FORMATION STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
86143
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
788352
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
72274
MEDICINAL FOLKLORE REPORTED FOR
BRONCHODILATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
859589
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
902505
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
838318
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN A
258710
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID GAMMA
79461
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID J
246144
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
1013171
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC
1185162
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDE FORMATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
228056
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-1
737186
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
79037
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID D
991054
PHARMACOLOGY OF COMPOUND - IN VIVOAMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE(GANODERMA LUCIDUM-PILEUS)
933660
CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID TGANODERIC ACID S
290653
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID SP-1
209496
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANOLACTONE
72285
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
794327
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
782231
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
228067
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL A
654385
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
609615
PHARMACOLOGY OF EXTRACT - IN VITRO
HYDROXIDE RADICAL GENERATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
122928
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE-2-BETA-3-ALPHA-9-ALPHA-TRIOL
89425
UV SPECTRUM GIVEN FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID I
79462
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANOLUCIDIC ACID C
246149
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMENONOL
263297
PHARMACOLOGY OF EXTRACT - IN VITRO
NAD(P)H:QUINONE REDUCTASE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIENE-3-22-DIONE,5-ALPHA: 26-HYDROXY:
228076
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
863728
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID MJ
584218
VOUCHER SPECIMEN REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
1284867
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LAURIC ACID
79032
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERENIC ACID C
1156010
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION A
713372
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
794326
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
258717
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ZETA
955506
PHARMACOLOGY OF COMPOUND - IN VITRO
INOTROPIC EFFECT POSITIVE
Ganoderma lucidum (GANODERMATACEAE)
CHRYSOPHANIC ACID GLUCOSIDE
228087
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
399115
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE I INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-STEAROYL-1-O-BETA-D-GLUCOPYRANOSYL-9-METHYL:
955493
PHARMACOLOGY OF COMPOUND - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID S-1
85548
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID F
228073
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL F
120909
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
74491
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID F
290656
UV SPECTRUM GIVEN FORQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
366641
PHARMACOLOGY OF EXTRACT - IN VIVO
ALKALINE PHOSPHATASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
286457
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID G,20-HYDROXY:
1156027
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION F
955511
PHARMACOLOGY OF COMPOUND - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANONTRIOL
123421
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANOSPORELACTONE A
228058
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-1
1156015
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION B
138794
PHARMACOLOGY OF COMPOUND - IN VITRO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-C
1296373
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INDUCTION
Ganoderma lucidum (GANODERMATACEAE)
687487
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
122927
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE-2-BETA-3-ALPHA-9-ALPHA-TRIOL
89432
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID O
652267
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID CLUCIDENIC ACID BGANODERIC ACID AGANODERMANOTRIOLGANODERIC ACID DGANODERIC ACID B
1302526
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
649849
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228078
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
693992
PHARMACOLOGY OF EXTRACT - IN VITRO
PHOSPHOLIPASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
79034
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID E
1149845
MEDICINAL FOLKLORE REPORTED FOR
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
401066
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
955514
PHARMACOLOGY OF COMPOUND - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-2
1208955
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
138783
PHARMACOLOGY OF COMPOUND - IN VIVO
PLAQUE FORMING CELL STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-A
629173
PHARMACOLOGY OF EXTRACT - IN VIVO
ALANINE AMINOTRANSFERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
116058
PHARMACOLOGY OF COMPOUND - IN VIVO
CELL PROLIFERATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA PROTEIN LING-ZHI 8
99221
PHARMACOLOGY OF COMPOUND - IN VITROISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
HEMAGGLUTININ ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
228065
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL A
123422
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANOSPORELACTONE B
871747
PRESENT IN (REVIEW)PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDCORRECTION OF STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMATRIOL TRIACETATEGANODERMADIOLGANODERMENONOLGANODERMANONTRIOL
929580
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
147577
IDENTIFICATION IN BY HPLC
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID HGANODERIC ACID A
1212590
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1201295
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
PALMITIC ACID
991053
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE(GANODERMA LUCIDUM-ROKUKAKUSHI)
86151
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID K
727432
IDENTIFICATION IN BY TLC
Ganoderma lucidum (GANODERMATACEAE)
URACILADENINEURIDINEADENOSINE
278998
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE NPBP
889459
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOCHOLESTEROLEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
943258
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
441748
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
229163
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA PEPTIDOGLYCAN TGLP-6GANODERMA PEPTIDOGLYCAN TGLP-7GANODERMA PEPTIDOGLYCAN PGLP-3GANODERMA PEPTIDOGLYCAN TGLP-2
1290860
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIEN-3-ONE,15-ALPHA-26-DIHYDROXY:
1297245
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOGLYCEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
566465
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228043
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
759345
PHARMACOLOGY OF EXTRACT - IN VITRO
INSECTICIDE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1020793
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC GL-2
829814
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
270120
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID N
679807
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
1185640
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID O,7-O-METHYL:
89421
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID M
929578
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
856824
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN C
566451
PHARMACOLOGY OF EXTRACT - IN VIVO
BILE SECRETION INCREASE
Ganoderma lucidum (GANODERMATACEAE)
258719
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID THETA
1208963
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERCHOLESTEROLEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
840029
IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GUANOSINE-5'-MONOPHOSPHATEXANTHOSINE-5'-MONOPHOSPHATE
902498
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
278999
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
81545
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDHPLC DATA REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID F
246145
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIEN-3-ONE
425646
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
649847
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
242509
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
242519
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
859587
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL A
782240
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H,DEACETYL:
286468
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
447603
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBED
Ganoderma lucidum (GANODERMATACEAE)
PROTEOGLYCAN-G009
72287
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
228072
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL F
1176015
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIASTHMATIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
399114
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE BETA INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-STEAROYL-1-O-BETA-D-GLUCOPYRANOSYL-9-METHYL:
740968
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
182320
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
228054
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
209535
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LANOST-8-EN-26-OIC ACID,5-ALPHA: 3-BETA-7-BETA-15-ALPHA-TRIHYDROXY-11-23-TRIOXO:
1183637
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
629177
PHARMACOLOGY OF COMPOUND - IN VIVO
ASPARTATE AMINOTRANSFERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERENIC ACID A
172362
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIEN-3-ALPHA-ACETOXY-26-OIC ACID
943261
PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
242514
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
399104
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE GAMMA INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-PALMITOYL-1-O-BETA-ED-GLUCOPYRANOSYL-9-METHYL:
595976
PHARMACOLOGY OF EXTRACT - IN VIVO
MACROPHAGE ACTIVATION
Ganoderma lucidum (GANODERMATACEAE)
1212589
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIPYRETIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
426143
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIISCHEMIC EFFECT
Ganoderma lucidum (GANODERMATACEAE)
782235
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID G
279002
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
441745
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
72704
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDONE B
79030
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERENIC ACID A
86316
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID T
263295
PHARMACOLOGY OF COMPOUND - IN VITRO
CYCLOOXYGENASE 1 INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIENE-3-22-DIONE,5-ALPHA: 26-27-DIHYDROXY:
421712
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
873845
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE
655653
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
782229
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1158195
PHARMACOLOGY OF EXTRACT - IN VITRO
PLAQUE FORMATION SUPPRESSANT
Ganoderma lucidum (GANODERMATACEAE)
228061
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
228047
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ALPHA
290658
UV SPECTRUM GIVEN FORQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID G
234589
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDUMOL B
597270
PHARMACOLOGY OF COMPOUND - IN VITRO
OXYGEN RADICAL INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE GLB
446055
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
955500
PHARMACOLOGY OF COMPOUND - IN VITRO
INOTROPIC EFFECT POSITIVE
Ganoderma lucidum (GANODERMATACEAE)
CHOLESTA-6-22-DIEN-3-BETA-OL,5-ALPHA-8-ALPHA-EPI-DIOXY-24-EPSILON-METHYL:
873182
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTILIPOLYTIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
973873
IDENTIFICATION IN BY TLCTLC DATA REPORTED
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID CGANODERIC ACID AGANODERIC ACID DGANODERIC ACID B
1156031
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION H
748878
PHARMACOLOGY OF EXTRACT - IN VIVO
LIPID PEROXIDE FORMATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
955487
PHARMACOLOGY OF EXTRACT - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
693991
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
450814
PHARMACOLOGY OF EXTRACT - IN VIVO
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
85550
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID D-2
1054977
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM HETEROGLYCAN
1185216
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
86140
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID D-2
74487
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID F
655662
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
629169
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
72699
PHARMACOLOGY OF COMPOUND - IN HUMANS
BITTER TASTING EFFECT
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID E
955497
PHARMACOLOGY OF COMPOUND - IN VITRO
INOTROPIC EFFECT POSITIVE
Ganoderma lucidum (GANODERMATACEAE)
GANODERAL A
401073
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
246141
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDADIOL
748877
PHARMACOLOGY OF EXTRACT - IN VIVO
RENAL FUNCTION IMPROVEMENT
Ganoderma lucidum (GANODERMATACEAE)
210480
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ACORENONE,15-HYDROXY:
242505
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
955486
PHARMACOLOGY OF EXTRACT - IN VITRO
CHRONOTROPIC EFFECT NEGATIVE
Ganoderma lucidum (GANODERMATACEAE)
773241
PHARMACOLOGY OF COMPOUND - IN VITRO
CALCIUM LEVEL INCREASE(INTRACELLULAR)
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE GLB-7
86147
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID F
74462
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID C
286464
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID I
426145
PHARMACOLOGY OF EXTRACT - IN VIVO
CORONARY BLOOD FLOW INCREASED
Ganoderma lucidum (GANODERMATACEAE)
89424
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID L
366644
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
738672
REVIEW OF
Ganoderma lucidum (GANODERMATACEAE)
863727
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID MH
941848
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID S
270116
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID N
610801
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERFERON-GAMMA PRODUCTION STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
399108
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE I INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-PALMITOYL-1-O-BETA-ED-GLUCOPYRANOSYL-9-METHYL:
711656
PHARMACOLOGY OF EXTRACT - IN VITRO
DNA SCISSION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1212600
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTICONVULSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
270135
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID F METHYL ESTER
441741
MEDICINAL FOLKLORE REPORTED FOR
APPETITE STIMULANT
Ganoderma lucidum (GANODERMATACEAE)
941268
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID
387206
PHARMACOLOGY OF COMPOUND - IN VITRO
GERANYLGERANYL-PROTEIN TRANSFERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
73085
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B METHYL ESTER
733787
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
207303
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
751783
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
425649
PHARMACOLOGY OF EXTRACT - IN VIVO
BARBITURATE SLEEPING TIME DECREASED
Ganoderma lucidum (GANODERMATACEAE)
873849
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTICONVULSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE
167344
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE,5'-DEOXY-5'-METHYL-SULFINYL:
398777
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1208960
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPERCHOLESTEROLEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
650009
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
79038
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
450815
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTHOCYANIN PRODUCTION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
509433
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-2 FORMATION STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
270130
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID E
1013208
PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM GLYCOPROTEIN
401088
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
923603
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPERTENSIVE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
863725
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID MI
654384
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
122924
VOUCHER SPECIMEN REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIEN-3-BETA-OL LINOLEATE
955498
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
CHOLESTA-6-22-DIEN-3-BETA-OL,5-ALPHA-8-ALPHA-EPI-DIOXY-24-EPSILON-METHYL:
234600
PHARMACOLOGY OF COMPOUND - IN VITRO
MEMBRANE POTENTIAL SHIFT
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
597269
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE GLB
943174
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
234603
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANOLUCIDIC ACID A
652265
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
650010
PHARMACOLOGY OF EXTRACT - IN VIVO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
969488
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-6-ALPHA-TRIOLERGOSTA-7-22-DIENE-3-BETA-5-ALPHA-6-BETA-TRIOLERGOSTA-4-6-8(14)-22-TETRAEN-3-ONEERGOSTEROL PALMITATEERGOSTEROLERGOSTA-7-9-22-TIRENE-3-BETA-5-ALPHA-6-ALPHA-TRIOL
457986
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1155663
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Ganoderma lucidum (GANODERMATACEAE)
953407
PHARMACOLOGY OF EXTRACT - IN VITRO
ADRENERGIC RECEPTOR BLOCKER(ALPHA-2)
Ganoderma lucidum (GANODERMATACEAE)
72277
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
228044
PHARMACOLOGY OF EXTRACT - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1156020
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION D
859467
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANONTRIOL
754926
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
657113
PHARMACOLOGY OF EXTRACT - IN VITRO
CARCINOGENESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
510743
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
902503
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1158196
PHARMACOLOGY OF EXTRACT - IN VITRO
PLAQUE FORMATION SUPPRESSANT
Ganoderma lucidum (GANODERMATACEAE)
754930
PHARMACOLOGY OF COMPOUND - IN VITRO
MELANIN FORMATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
266181
PHARMACOLOGY OF COMPOUND - IN VITRO
LYMPHOCYTE(B) STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE SP
687488
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
955482
MEDICINAL FOLKLORE REPORTED FOR
DIGESTANT ACTION
Ganoderma lucidum (GANODERMATACEAE)
1156016
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION C
242511
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
207307
PHARMACOLOGY OF COMPOUND - IN VITRO
IMMUNOSUPPRESSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
228057
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-1
270127
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID A
787814
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
649850
VOUCHER SPECIMEN REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
399103
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE II INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-PALMITOYL-1-O-BETA-ED-GLUCOPYRANOSYL-9-METHYL:
895320
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
172327
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMIC ACID SGANODERMIC ACID R
595977
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
848915
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID VGANODERIC ACID XGANODERIC ACID WGANODERIC ACID YGANODERIC ACID UGANODERIC ACID Z
741521
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228066
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL A
228077
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
666062
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
167348
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE,5'-DEOXY-5'-METHYL-SULFINYL: 1-EPI:
286453
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOMODULATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID J,8-BETA-9-ALPHA-DIHYDRO:
1185638
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID Q
783210
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
209498
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIENE-3-BETA-26-DIOL,5-ALPHA:
1149849
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIALLERGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1020797
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC GL-3
1174681
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIALLERGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
794325
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228094
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:
1024543
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID VGANODERIC ACID XGANODERIC ACID TGANODERIC ACID WGANODERIC ACID YGANODERIC ACID Z
86155
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM TRITERPENE 6-A
896725
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOGLYCEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
138787
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-B
684346
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INDUCTION
Ganoderma lucidum (GANODERMATACEAE)
860886
PHARMACOLOGY OF COMPOUND - IN VIVO
DNA STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
LINGZHI POLYSACCHARIDE D-6
1212586
MEDICINAL FOLKLORE REPORTED FOR
CNS DEPRESSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
72280
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID D
387202
PHARMACOLOGY OF COMPOUND - IN VITRO
FARNESYLTRANSFERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
72272
MEDICINAL FOLKLORE REPORTED FOR
APPETITE STIMULANT
Ganoderma lucidum (GANODERMATACEAE)
838565
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
769991
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
686230
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID CGANODERIC ACID EGANODERIC ACID BGANOSPORERIC ACIDGANODERMANONTRIOL
955510
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANONTRIOL
1201294
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
PALMITIC ACID
277144
PHARMACOLOGY OF COMPOUND - IN VITRO
TUMOR NECROSING FACTOR RELEASE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE GLB
120910
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID E
1296566
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL MIGRATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
929583
PHARMACOLOGY OF EXTRACT - IN HUMANS
ANTICOAGULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
138791
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-C
566449
PHARMACOLOGY OF EXTRACT - IN VIVO
BILE SECRETION INCREASE
Ganoderma lucidum (GANODERMATACEAE)
228055
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
242522
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
286471
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID AM-1
694512
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
74484
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANOLUCIDIC ACID B
270124
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID A
228068
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL B
1198630
PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR
GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
73084
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENTINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A METHYL ESTER
263296
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIENE-3-22-DIONE,5-ALPHA: 26-HYDROXY:
286460
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDONE A
234595
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
234584
PHARMACOLOGY OF EXTRACT - IN VITRO
MEMBRANE POTENTIAL SHIFT
Ganoderma lucidum (GANODERMATACEAE)
566455
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
138789
PHARMACOLOGY OF COMPOUND - IN VIVO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-B
1212597
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIPYRETIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1174677
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
838317
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOGLYCEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
856820
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPOGLYCEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN B
610799
PHARMACOLOGY OF EXTRACT - IN VITRO
PHAGOSOME-LYSOSOME FUSION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1156026
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION F
286449
PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID J,8-BETA-9-ALPHA-DIHYDRO:
278995
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE NPBP
234592
PHARMACOLOGY OF COMPOUND - IN VITRO
MEMBRANE POTENTIAL SHIFT
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANODIOL
1201287
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
OLEIC ACID
228050
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
1296569
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL MIGRATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
397634
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
228083
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
74486
CMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID E
1302530
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANONTRIOL
399105
PHARMACOLOGY OF COMPOUND - IN VITRO
TRYPSIN INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-PALMITOYL-1-O-BETA-ED-GLUCOPYRANOSYL-9-METHYL:
629167
PHARMACOLOGY OF EXTRACT - IN VITRO
BETA-GLUCURONIDASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
182316
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANOSPORERIC ACID
228053
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
426142
PHARMACOLOGY OF EXTRACT - IN VITRO
CORONARY VASODILATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
445769
PHARMACOLOGY OF EXTRACT - IN VIVO
NATURAL KILLER CELL ENHANCEMENT
Ganoderma lucidum (GANODERMATACEAE)
636101
VOUCHER SPECIMEN REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
441746
PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
642229
EFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
PSA(PROSTATE-SPECIFIC ANTIGEN) PRODUCTION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
246146
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
769990
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
610804
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INDUCTION
Ganoderma lucidum (GANODERMATACEAE)
955483
MEDICINAL FOLKLORE REPORTED FOR
CNS DEPRESSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1212593
PHARMACOLOGY OF EXTRACT - IN VIVO
SKELETAL MUSCLE RELAXANT EFFECT(CENTRAL)
Ganoderma lucidum (GANODERMATACEAE)
263294
PHARMACOLOGY OF COMPOUND - IN VITRO
NAD(P)H:QUINONE REDUCTASE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIENE-3-22-DIONE,5-ALPHA: 26-27-DIHYDROXY:
859588
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL B
1284866
PHARMACOLOGY OF EXTRACT - IN VITRO
MISCELLANEOUS EFFECTS
Ganoderma lucidum (GANODERMATACEAE)
1207229
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
79035
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID F
991052
PHARMACOLOGY OF COMPOUND - IN VIVOAMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE(GANODERMA LUCIDUM-ROKUKAKUSHI)
72697
PHARMACOLOGY OF COMPOUND - IN HUMANS
BITTER TASTING EFFECT
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID D
242518
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
421716
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERFERON SECRETION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
89427
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERENIC ACID E
228042
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID ALPHA
973874
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
207308
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
787815
PHARMACOLOGY OF EXTRACT - IN VITRO
SUPEROXIDE DISMUTASE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
965967
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID T
566466
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
72284
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
929579
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
906982
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA ACIDIC POLYSACCHARIDE GL-A
1020794
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC GL-2
72700
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDONE A
89422
UV SPECTRUM GIVEN FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID E-2
741523
PHARMACOLOGY OF EXTRACT - IN VITRO
MITOGEN-ACTIVATED PROTEIN KINASE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
86139
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID C
856823
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPOGLYCEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN C
172361
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIEN-3-ALPHA-ACETOXY-26-OIC ACID
85549
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
387205
PHARMACOLOGY OF COMPOUND - IN VITRO
FARNESYLTRANSFERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
824361
PHARMACOLOGY OF EXTRACT - IN VIVO
RNA SYNTHESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
955490
PHARMACOLOGY OF EXTRACT - IN VITRO
INOTROPIC EFFECT POSITIVE
Ganoderma lucidum (GANODERMATACEAE)
782236
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID G
655661
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
72283
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
228064
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL A
84808
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERMADIOL
873848
PHARMACOLOGY OF COMPOUND - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE
694513
PHARMACOLOGY OF EXTRACT - IN VIVO
NATURAL KILLER CELL ENHANCEMENT
Ganoderma lucidum (GANODERMATACEAE)
1156023
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION E
1156012
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION A
953412
PHARMACOLOGY OF EXTRACT - IN VITRO
HGPRT INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
397633
IDENTIFICATION IN BY GLCQUANTITATIVE DATA REPORTED
Ganoderma lucidum (GANODERMATACEAE)
TETRADEC-CIS-9-ENOIC ACIDPALMITOLEIC ACIDPALMITIC ACIDLINOLEIC ACIDOLEIC ACID
1020792
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC GL-1
228059
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-1
89433
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C,7-EPI:
116057
PHARMACOLOGY OF COMPOUND - IN VIVOTOXICITY MARKER CODE
TOXIC EFFECT(GENERAL)
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA PROTEIN LING-ZHI 8
972897
QUANTITATIVE DATAIDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GERMANIUM
1156017
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION C
86144
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-1
838320
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPOGLYCEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN A
242523
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
279000
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
1284870
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LINOLEIC ACID
1174683
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIALLERGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
270133
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID E
509434
PHARMACOLOGY OF EXTRACT - IN VITRO
LYMPHOCYTE PROLIFERATION STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
1209308
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
120907
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANOSPOREIC ACID
242512
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
366642
PHARMACOLOGY OF EXTRACT - IN VIVO
ALANINE TRANSAMINASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
773095
VOUCHER SPECIMEN REPORTED FORPCR ANALYSIS(PLANT)
Ganoderma lucidum (GANODERMATACEAE)
679808
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
885422
PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED
ANTIHYPERTENSIVE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
286450
PHARMACOLOGY OF EXTRACT - IN VITRO
IMMUNOMODULATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID J,8-BETA-9-ALPHA-DIHYDRO:
955512
PHARMACOLOGY OF COMPOUND - IN VITRO
INOTROPIC EFFECT POSITIVE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANONTRIOL
1185641
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID O
493121
PHARMACOLOGY OF COMPOUND - IN VITRO
CELL AGGREGATION ENHANCEMENT
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
425650
PHARMACOLOGY OF EXTRACT - IN VIVO
LIVER REGENERATION EFFECTS
Ganoderma lucidum (GANODERMATACEAE)
399113
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE ALPHA INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-STEAROYL-1-O-BETA-D-GLUCOPYRANOSYL-9-METHYL:
86317
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID S
629178
PHARMACOLOGY OF COMPOUND - IN VIVO
ALANINE AMINOTRANSFERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERENIC ACID A
1028139
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATACOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
399109
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-STEAROYL-1-O-BETA-D-GLUCOPYRANOSYL-9-METHYL:
943260
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
637257
VOUCHER SPECIMEN REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
493759
PHARMACOLOGY OF EXTRACT - IN VITRO
THYMIDINE UPTAKE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
838562
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
902497
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228092
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:
1324240
TRADITIONAL MEDICINEEFFECTS DUE TO A COMBINATION OF DRUGSCLINICAL STUDIES
ANTIINFLAMMATORY ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1149846
PHARMACOLOGY OF EXTRACT - IN VIVO
ADAPTOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1208956
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
655654
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
72705
PHARMACOLOGY OF COMPOUND - IN HUMANS
BITTER TASTING EFFECT
Ganoderma lucidum (GANODERMATACEAE)
LUCIDONE B
246142
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDAL
138790
PHARMACOLOGY OF COMPOUND - IN VITRO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-B
228060
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
147576
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID V-1
234588
PHARMACOLOGY OF COMPOUND - IN VITRO
MEMBRANE POTENTIAL SHIFT
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID,BETA:
366643
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
445771
PHARMACOLOGY OF EXTRACT - IN VIVO
MACROPHAGE ACTIVATION
Ganoderma lucidum (GANODERMATACEAE)
116054
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA PROTEIN LING-ZHI 8
687292
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
694518
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIPROLIFERATION ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228074
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL F
228071
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL B
228081
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
74481
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID G
72288
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
829813
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID C
201949
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOMODULATOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
693990
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
652264
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1156014
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION B
1174678
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
666065
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIMALARIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
533247
PHARMACOLOGY OF EXTRACT - IN VITRO
RADICAL SCAVENGING EFFECT
Ganoderma lucidum (GANODERMATACEAE)
1208964
PHARMACOLOGY OF EXTRACT - IN VIVO
WEIGHT INCREASE
Ganoderma lucidum (GANODERMATACEAE)
1302527
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE,9(11)-DEHYDRO:
649846
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1020790
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC GL-1
72698
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID E
686397
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
760436
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
629172
PHARMACOLOGY OF EXTRACT - IN VIVO
ASPARTATE AMINOTRANSFERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
81544
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDHPLC DATA REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID E
73083
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C
207304
PHARMACOLOGY OF COMPOUND - IN VITRO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
234598
PHARMACOLOGY OF COMPOUND - IN VITRO
MEMBRANE POTENTIAL SHIFT
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
258716
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID EPSILON
447916
PHARMACOLOGY OF EXTRACT - IN HUMANS
BLOOD VISCOSITY DECREASED
Ganoderma lucidum (GANODERMATACEAE)
228088
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
CEREVISTEROL
1322757
TRADITIONAL MEDICINEPHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS
ANTIINFLAMMATORY ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
953411
PHARMACOLOGY OF EXTRACT - IN VITRO
CHOLECYSTOKININ RECEPTOR BINDING EFFECT
Ganoderma lucidum (GANODERMATACEAE)
955501
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
CHRYSOPHANIC ACID
228048
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
1176016
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTINEPHROTOXIC
Ganoderma lucidum (GANODERMATACEAE)
941849
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID R
943264
PHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1155662
PHARMACOLOGY OF EXTRACT - IN VIVOTOXICITY MARKER CODE
TOXICITY ASSESSMENT(QUANTITATIVE)
Ganoderma lucidum (GANODERMATACEAE)
1212598
PHARMACOLOGY OF EXTRACT - IN VIVO
BARBITURATE SLEEPING TIME DECREASED
Ganoderma lucidum (GANODERMATACEAE)
242515
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC LACTONE
223226
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-B-IGANODERMA POLYSACCHARIDE BN-3-B-II
72276
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
953408
PHARMACOLOGY OF EXTRACT - IN VITRO
ANGIOTENSIN-II INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
991051
PHARMACOLOGY OF COMPOUND - IN VIVOAMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTUREANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE(GANODERMA LUCIDUM-STIPE)
228084
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
657112
PHARMACOLOGY OF EXTRACT - IN VITRO
CARCINOGENESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
1280378
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENE,2'(R)-HYDROXY-PALMITOYL-9-METHYL: 1-O-BETA-D-GLUCOSIDE 2(S)-3(R):SPHINGA-4-8-DIENE,2'-HYDROXY-OCTADEC-3'ENOYL-9-METHYL; 1-O-BETA-D-GLUCOSIDESPHINGA-TRANS-4-TRANS-8-DIEN,2'(R)-HYDROXY-HEXADEC-TRANS-3'-ENOYL-9-METHYL: 1-O-BETA-D-GLUCOSIDE 2(S)-3(R):OCTADECANE-1-3-4-TRIHYDROXY,2-[(2-HYDROXY-TETRACOSANOYL)-AMINO];
694515
PHARMACOLOGY OF EXTRACT - IN VIVO
NATURAL KILLER CELL ENHANCEMENT
Ganoderma lucidum (GANODERMATACEAE)
138784
PHARMACOLOGY OF COMPOUND - IN VIVO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-A
848916
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID VGANODERIC ACID XGANODERIC ACID WGANODERIC ACID YGANODERIC ACID Z
773545
PHARMACOLOGY OF EXTRACT - IN VIVO
CALCIUM LEVEL DECREASE(EXTRACELLULAR)
Ganoderma lucidum (GANODERMATACEAE)
493119
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
829364
MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATA REPORTEDIDENTIFICATION IN BY GC/MS
Ganoderma lucidum (GANODERMATACEAE)
CHOLESTA-7-22-DIEN-3-BETA-OL,24-METHYL:ERGOSTEROLLATHOSTEROL,24-METHYL:CHOLESTAN-3-BETA-OL,24-ETHYL:
228070
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL B
246150
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID DM
399102
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
SPHINGA-TRANS-4-TRANS-8-DIENINE,N-D-2'-HYDROXY-PALMITOYL-1-O-BETA-ED-GLUCOPYRANOSYL-9-METHYL:
290655
UV SPECTRUM GIVEN FORQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID A
782492
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
666066
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIMALARIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
782233
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
794329
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1207231
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHISTAMINE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
CYCLOOCTASULFUR
286467
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID H
86141
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID E-2
1201290
PHARMACOLOGY OF COMPOUND - IN VITRO
CALCIUM ION UPTAKE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
OLEIC ACID
371001
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
687486
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
1174680
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIALLERGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
783211
PHARMACOLOGY OF EXTRACT - IN VIVO
METASTASIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
566454
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIULCER ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
610802
PHARMACOLOGY OF EXTRACT - IN VITRO
APOPTOSIS INDUCTION
Ganoderma lucidum (GANODERMATACEAE)
860887
PHARMACOLOGY OF COMPOUND - IN VIVO
PROTEIN SYNTHESIS STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
LINGZHI POLYSACCHARIDE D-6
138795
PHARMACOLOGY OF COMPOUND - IN VITRO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE BN-3-C
711655
PHARMACOLOGY OF EXTRACT - IN VITRO
HYDROGEN PEROXIDE SCAVENGER ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
279001
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE APBP
955491
PHARMACOLOGY OF EXTRACT - IN VITRO
INOTROPIC EFFECT POSITIVE
Ganoderma lucidum (GANODERMATACEAE)
270128
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID A
510744
PHARMACOLOGY OF EXTRACT - IN VITRO
DNA SYNTHESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
902502
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
421713
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL DIFFERENTIATION INDUCTION
Ganoderma lucidum (GANODERMATACEAE)
949201
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
277145
PHARMACOLOGY OF COMPOUND - IN VITRO
INTERFERON INDUCTION STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE GLB
234593
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL F
1185634
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDHPLC DATA REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-4-7-22-TRIENE-3-6-DIONE
754929
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIPROLIFERATION ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
242506
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
929582
PHARMACOLOGY OF EXTRACT - IN HUMANS
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
234587
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID,BETA:
1185636
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID S
955504
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
CHRYSOPHANIC ACID GLUCOSIDE
794324
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
426146
PHARMACOLOGY OF EXTRACT - IN VIVO
CORONARY BLOOD FLOW INCREASED
Ganoderma lucidum (GANODERMATACEAE)
741522
PHARMACOLOGY OF EXTRACT - IN VITRO
CELL DIFFERENTIATION INDUCTION
Ganoderma lucidum (GANODERMATACEAE)
923600
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOTENSIVE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
561363
PHARMACOLOGY OF EXTRACT - IN VIVO
IMMUNOSTIMULANT ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
270123
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID A
1185637
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID R
234596
PHARMACOLOGY OF COMPOUND - IN VITRO
MEMBRANE POTENTIAL SHIFT
Ganoderma lucidum (GANODERMATACEAE)
GANODERMANOTRIOL
943175
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
86145
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-2
655659
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
228095
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEASE(HIV) INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE,3-BETA-5-ALPHA-DIHYDROXY-6-BETA-METHOXY:
122926
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTA-7-22-DIENE-2-BETA-3-ALPHA-9-ALPHA-TRIOL
445770
PHARMACOLOGY OF EXTRACT - IN VIVO
LYMPHOCYTE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
856818
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPOGLYCEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
441742
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
657116
PHARMACOLOGY OF EXTRACT - IN VITRO
CARCINOGENESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
234599
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
228080
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL
955515
PHARMACOLOGY OF COMPOUND - IN VITRO
INOTROPIC EFFECT POSITIVE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-2
1212587
MEDICINAL FOLKLORE REPORTED FOR
DIGESTANT ACTION
Ganoderma lucidum (GANODERMATACEAE)
425648
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTITOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
760438
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
234601
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID C-1
955509
PHARMACOLOGY OF COMPOUND - IN VITRO
INOTROPIC EFFECT POSITIVE
Ganoderma lucidum (GANODERMATACEAE)
PORTENSTEROL
1290856
PHARMACOLOGY OF EXTRACT - IN VITRO
REDUCTASE,5-ALPHA: INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
278996
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE NPBP
1176018
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIALLERGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1284869
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
OLEIC ACID
943259
PHARMACOLOGY OF EXTRACT - IN VITRO
PEPSIN INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
848914
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID U
871556
PHARMACOLOGY OF EXTRACT - IN VIVO
CHOLERETIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
234585
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
LUCIDUMOL A
228069
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL B
1156028
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION G
493120
PHARMACOLOGY OF COMPOUND - IN VITRO
MITOGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LING-ZHI 8
89423
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID K
120908
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID B
270117
PHARMACOLOGY OF COMPOUND - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID N
266180
PHARMACOLOGY OF COMPOUND - IN VITRO
T-LYMPHOCYTE STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA POLYSACCHARIDE SP
1201288
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
OLEIC ACID
566462
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
457985
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
955494
PHARMACOLOGY OF COMPOUND - IN VITRO
INOTROPIC EFFECT POSITIVE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID S-1
566460
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
270134
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID C
273892
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
POLYSACCHARIDE LB-NB
783215
PHARMACOLOGY OF COMPOUND - IN VITRO
ANGIOGENESIS INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID F
258713
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID DELTA
85552
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM COMPOUND C-6
751784
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIMUTAGENIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1156025
GEL PERMEATION CHROMATOGRAPHY USEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM POLYSACCHARIDE FRACTION F
447917
PHARMACOLOGY OF EXTRACT - IN HUMANS
HYPOTENSIVE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
754927
PHARMACOLOGY OF COMPOUND - IN VITRO
MELANIN FORMATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ERGOSTEROL PEROXIDE
209499
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
LANOSTA-7-9(11)-24-TRIENE-3-BETA-26-27-TRIOL,5-ALPHA:
234604
PHARMACOLOGY OF COMPOUND - IN VITRO
MEMBRANE POTENTIAL SHIFT
Ganoderma lucidum (GANODERMATACEAE)
GANOLUCIDIC ACID A
962164
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
1283851
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIPROLIFERATION ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
713373
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOTOXIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
242502
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA POLYMERASE INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID O
11718
PHYTOCHEMICAL SCREENING FOR
Ganoderma lucidum (GANODERMATACEAE)
O
923604
PHARMACOLOGY OF EXTRACT - IN VIVO
HYPERTENSIVE ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
649851
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
86146
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID E
86152
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANOLUCIDENIC ACID A
860884
PHARMACOLOGY OF COMPOUND - IN VIVO
RNA SYNTHESIS STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
LINGZHI POLYSACCHARIDE D-6
838323
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPOGLYCEMIC ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERAN B
1283707
ISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID T
842134
GEL PERMEATION CHROMATOGRAPHY USEDHPLC DATA REPORTEDISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE
860890
PHARMACOLOGY OF COMPOUND - IN VIVO
PROTEIN SYNTHESIS STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
LINGZHI POLYSACCHARIDE D-6
167347
PHARMACOLOGY OF COMPOUND - IN VITRO
PLATELET AGGREGATION INHIBITION
Ganoderma lucidum (GANODERMATACEAE)
ADENOSINE,5'-DEOXY-5'-METHYL-SULFINYL: 1-EPI:
286456
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Ganoderma lucidum (GANODERMATACEAE)
GANODERIC ACID J,8-BETA-9-ALPHA-DIHYDRO: METHYL ESTER
286461
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Ganoderma lucidum (GANODERMATACEAE)
GANODERIOL B
610798
PHARMACOLOGY OF EXTRACT - IN VITRO
INTERLEUKIN-1 FORMATION STIMULATION
Ganoderma lucidum (GANODERMATACEAE)
279678
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Ganoderma lucidum (GANODERMATACEAE)
LUCIDENIC ACID CLUCIDENIC ACID ALUCIDENIC ACID LM-1
1020791
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Ganoderma lucidum (GANODERMATACEAE)
GANODERMA LUCIDUM ANTIBIOTIC GL-1